Anti-Diabetic Archives - Sigma Softgel & Formulation

Code

Composition

Dosages

Description

DT201

Tablet
Cardio-Diabetic

Product Details
Composition	Dapagliflozin 10mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT211

Each uncoated bilayered tablet Vildagliptin I.P. 50 mg and Metformin Hydrochloride I.P 1000 mg (as sustained release form)

Tablet
Cardio-Diabetic

Product Details
Composition	Each uncoated bilayered tablet Vildagliptin I.P. 50 mg and Metformin Hydrochloride I.P 1000 mg (as sustained release form)
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT210

Each uncoated Mouth Dissolving Voglibose I.P. 0.2 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Each uncoated Mouth Dissolving Voglibose I.P. 0.2 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT212

Each uncoated sustained release tablet contains Vildagliptin I.P. 100 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Each uncoated sustained release tablet contains Vildagliptin I.P. 100 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT213

Each uncoated tablet contains Vildagliptin I.P. 100 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Each uncoated tablet contains Vildagliptin I.P. 100 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT206

Gliclazide I.P. 60mg, Metformin Hydrochloride (As extended release) I.P. 500mg

Tablet
Cardio-Diabetic

Product Details
Composition	Gliclazide I.P. 60mg, Metformin Hydrochloride (As extended release) I.P. 500mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT177

Gliclazide I.P. 80mg, Metformin Hydrochloride (As extended- release Form) I.P. 500 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Gliclazide I.P. 80mg, Metformin Hydrochloride (As extended- release Form) I.P. 500 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT209

Gliclazide I.P. 80mg, Metformin Hydrochloride I.P. 500mg

Tablet
Cardio-Diabetic

Product Details
Composition	Gliclazide I.P. 80mg, Metformin Hydrochloride I.P. 500mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT178

Glimepiride I.P. 1mg

Tablet
Cardio-Diabetic

Product Details
Composition	Glimepiride I.P. 1mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT179

Glimepiride I.P. 2mg

Tablet
Cardio-Diabetic

Product Details
Composition	Glimepiride I.P. 2mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT180

Glimepiride I.P. 4mg

Tablet
Cardio-Diabetic

Product Details
Composition	Glimepiride I.P. 4mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT160

Glimepiride IP 1 mg, Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 500 mg, (As sustained release form)

Tablet
Cardio-Diabetic

Product Details
Composition	Glimepiride IP 1 mg, Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 500 mg, (As sustained release form)
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT161

Glimepiride IP 2 mg, Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg, Metformin Hydrochloride 500 mg (As Sustained Release form)

Tablet
Cardio-Diabetic

Product Details
Composition	Glimepiride IP 2 mg, Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg, Metformin Hydrochloride 500 mg (As Sustained Release form)
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT135

Metformin Hydrochloride (As Prolonged Release Form) I.P. 1000 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Metformin Hydrochloride (As Prolonged Release Form) I.P. 1000 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT134

Metformin Hydrochloride (As Prolonged Release Form) I.P. 500 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Metformin Hydrochloride (As Prolonged Release Form) I.P. 500 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT136

Metformin Hydrochloride (As Prolonged Release Form) I.P. 500 mg & Glimepiride I.P. 1 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Metformin Hydrochloride (As Prolonged Release Form) I.P. 500 mg & Glimepiride I.P. 1 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT140

Metformin Hydrochloride I.P. (As Extended Release Form) 500 mg & Teneligliptin Hydrobromide Hydrate I.P. eq. to Teneligliptin 20 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Metformin Hydrochloride I.P. (As Extended Release Form) 500 mg & Teneligliptin Hydrobromide Hydrate I.P. eq. to Teneligliptin 20 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT141

Metformin Hydrochloride I.P. (As Sustained Release Form) 1000 mg & Teneligliptin Hydrobromide Hydrate I.P. eq. to Teneligliptin 20 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Metformin Hydrochloride I.P. (As Sustained Release Form) 1000 mg & Teneligliptin Hydrobromide Hydrate I.P. eq. to Teneligliptin 20 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT138

Metformin Hydrochloride I.P. (As Sustained Release Form) 500 mg & Voglibose I.P. 0.3 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Metformin Hydrochloride I.P. (As Sustained Release Form) 500 mg & Voglibose I.P. 0.3 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT53

Metformin Hydrochloride I.P. (in prolonged release form) 500 mg, Glimepiride I.P. 2 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Metformin Hydrochloride I.P. (in prolonged release form) 500 mg, Glimepiride I.P. 2 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT74

Metformin Hydrochloride I.P. 1000 mg (As Prolonged Release Form) Glimepiride I.P. 1 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Metformin Hydrochloride I.P. 1000 mg (As Prolonged Release Form) Glimepiride I.P. 1 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT75

Metformin Hydrochloride I.P. 1000 mg (As Prolonged Release Form) Glimepiride I.P.2 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Metformin Hydrochloride I.P. 1000 mg (As Prolonged Release Form) Glimepiride I.P.2 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT184

Metformin Hydrochloride I.P. 100mg, Vildagliptin I.P. 50 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Metformin Hydrochloride I.P. 100mg, Vildagliptin I.P. 50 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT142

Metformin Hydrochloride I.P. 500 mg & Vildagliptin 50 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Metformin Hydrochloride I.P. 500 mg & Vildagliptin 50 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT157

Metformin Hydrochloride IP 500 mg, (As Prolonged Release Form) Glimepiride IP 1 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Metformin Hydrochloride IP 500 mg, (As Prolonged Release Form) Glimepiride IP 1 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT139

Teneligliptin Hydrobromide Hydrtae I.P. eq. to Teneligliptin 20 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Teneligliptin Hydrobromide Hydrtae I.P. eq. to Teneligliptin 20 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT200

Vildagliptin I.P. 50mg

Tablet
Cardio-Diabetic

Product Details
Composition	Vildagliptin I.P. 50mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT137

Voglibose I.P. 0.2 mg

Tablet
Cardio-Diabetic

Product Details
Composition	Voglibose I.P. 0.2 mg
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic

More Details

DT192

Voglibose I.P. 0.2mg, Metformin Hydrochloride I.P. 500mg (As sustained release form)

Tablet
Cardio-Diabetic

Product Details
Composition	Voglibose I.P. 0.2mg, Metformin Hydrochloride I.P. 500mg (As sustained release form)
Dosage Form	Tablet
Type	Drug
Packaging	10x10
Category	Anti-Diabetic
Department	Cardio-Diabetic